Sfoglia per Autore
Letter: Alkylating agents and myeloma cells.
1976 A., Pileri; Conte, Pierfranco; N., Hulin
Early recruitment in the human myeloma cell population after cytostatic treatment.
1976 A., Pileri; M. G., Bernengo; M., Boccadoro; Conte, Pierfranco; C., Marinone; P., Masera
Breakdown of RNA and protein synthesis template stability in proliferating and non proliferating human myeloma cells.
1977 A., Pileri; Conte, Pierfranco; M., Boccadoro; N., Hulin
The biological and clinical features of human myeloma.
1977 A., Pileri; Conte, Pierfranco
B lymphocytes receptors: a new biological approach for immunofluorescence studies.
1977 Conte, Pierfranco; M., Boccadoro; A., Pileri
Biology of the human myeloma cell population. II. Cytokinetic characteristics.
1978 N., Hulin; Conte, Pierfranco; A., Pileri
Early B lymphocytes in man.
1980 Conte, Pierfranco; M., Boccadoro; A., Pileri
Combination chemotherapy for metastatic brain tumors.
1981 Conte, Pierfranco; G., Giaccone; R., Musella; A., Calciati
Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancer.
1984 Conte, Pierfranco; A., Alama; R., Favoni; F., Trave; R., Rosso; A., Nicolin
Ineffectiveness of 5-fluorouracil and cis-platin as second-line chemotherapy in head and neck cancer.
1984 M., Merlano; Conte, Pierfranco; R., Tatarek; P., Scarsi; A., Barbieri; G., Benedetti; R., Rosso
Non-functioning parathyroid carcinoma: a case report.
1985 M., Merlano; Conte, Pierfranco; P., Scarsi; R., Tatarek; A., Barbieri; A., Santelli; D., Scarpati; P. D., Angelis
Aminoglutethimide as second-line endocrine treatment in metastatic breast cancer.
1985 P., Pronzato; A., Ardizzoni; R., Lionetto; Conte, Pierfranco; R., Rosso
Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer.
1985 Conte, Pierfranco; G., Fraschini; A., Alama; A., Nicolin; E., Corsaro; G., Canavese; R., Rosso; B., Drewinko
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer.
1985 Conte, Pierfranco; M. R., Sertoli; M., Bruzzone; A., Rubagotti; R., Rosso; G., Bentivoglio; A., Conio; G., Pescetto
Estrogen induced expansion of the growth fraction in receptor negative human breast cancer.
1985 Conte, Pierfranco; G., Fraschini; B., Drewinko
Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase.
1986 A., Alama; Conte, Pierfranco; E. D., Marco; R. E., Favoni; A., Nicolin
Survival of patients with relapsing breast cancer: analysis of 302 patients.
1986 R., Lionetto; P., Pronzato; G. F., Bertelli; A., Ardizzoni; Conte, Pierfranco; R., Rosso
A phase II study of mitoxantrone in advanced breast cancer.
1986 P., Pronzato; A., Ardizzoni; Conte, Pierfranco; M., Gulisano; R., Lionetto; L., Repetto; V., Scornavacche; M. R., Sertoli; R., Rosso
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.
1986 Conte, Pierfranco; M., Bruzzone; S., Chiara; M. R., Sertoli; M. G., Daga; A., Rubagotti; A., Conio; M., Ruvolo; R., Rosso; L., Santi
Idarubicin in advanced breast cancer: a phase II study.
1986 R., Lionetto; P., Pronzato; Conte, Pierfranco; M. R., Sertoli; D., Amoroso; R., Rosso
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Letter: Alkylating agents and myeloma cells. | 1-gen-1976 | A., Pileri; Conte, Pierfranco; N., Hulin | |
Early recruitment in the human myeloma cell population after cytostatic treatment. | 1-gen-1976 | A., Pileri; M. G., Bernengo; M., Boccadoro; Conte, Pierfranco; C., Marinone; P., Masera | |
Breakdown of RNA and protein synthesis template stability in proliferating and non proliferating human myeloma cells. | 1-gen-1977 | A., Pileri; Conte, Pierfranco; M., Boccadoro; N., Hulin | |
The biological and clinical features of human myeloma. | 1-gen-1977 | A., Pileri; Conte, Pierfranco | |
B lymphocytes receptors: a new biological approach for immunofluorescence studies. | 1-gen-1977 | Conte, Pierfranco; M., Boccadoro; A., Pileri | |
Biology of the human myeloma cell population. II. Cytokinetic characteristics. | 1-gen-1978 | N., Hulin; Conte, Pierfranco; A., Pileri | |
Early B lymphocytes in man. | 1-gen-1980 | Conte, Pierfranco; M., Boccadoro; A., Pileri | |
Combination chemotherapy for metastatic brain tumors. | 1-gen-1981 | Conte, Pierfranco; G., Giaccone; R., Musella; A., Calciati | |
Timed sequential chemotherapy following drug-induced kinetic recruitment in refractory ovarian cancer. | 1-gen-1984 | Conte, Pierfranco; A., Alama; R., Favoni; F., Trave; R., Rosso; A., Nicolin | |
Ineffectiveness of 5-fluorouracil and cis-platin as second-line chemotherapy in head and neck cancer. | 1-gen-1984 | M., Merlano; Conte, Pierfranco; R., Tatarek; P., Scarsi; A., Barbieri; G., Benedetti; R., Rosso | |
Non-functioning parathyroid carcinoma: a case report. | 1-gen-1985 | M., Merlano; Conte, Pierfranco; P., Scarsi; R., Tatarek; A., Barbieri; A., Santelli; D., Scarpati; P. D., Angelis | |
Aminoglutethimide as second-line endocrine treatment in metastatic breast cancer. | 1-gen-1985 | P., Pronzato; A., Ardizzoni; R., Lionetto; Conte, Pierfranco; R., Rosso | |
Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer. | 1-gen-1985 | Conte, Pierfranco; G., Fraschini; A., Alama; A., Nicolin; E., Corsaro; G., Canavese; R., Rosso; B., Drewinko | |
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer. | 1-gen-1985 | Conte, Pierfranco; M. R., Sertoli; M., Bruzzone; A., Rubagotti; R., Rosso; G., Bentivoglio; A., Conio; G., Pescetto | |
Estrogen induced expansion of the growth fraction in receptor negative human breast cancer. | 1-gen-1985 | Conte, Pierfranco; G., Fraschini; B., Drewinko | |
Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase. | 1-gen-1986 | A., Alama; Conte, Pierfranco; E. D., Marco; R. E., Favoni; A., Nicolin | |
Survival of patients with relapsing breast cancer: analysis of 302 patients. | 1-gen-1986 | R., Lionetto; P., Pronzato; G. F., Bertelli; A., Ardizzoni; Conte, Pierfranco; R., Rosso | |
A phase II study of mitoxantrone in advanced breast cancer. | 1-gen-1986 | P., Pronzato; A., Ardizzoni; Conte, Pierfranco; M., Gulisano; R., Lionetto; L., Repetto; V., Scornavacche; M. R., Sertoli; R., Rosso | |
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. | 1-gen-1986 | Conte, Pierfranco; M., Bruzzone; S., Chiara; M. R., Sertoli; M. G., Daga; A., Rubagotti; A., Conio; M., Ruvolo; R., Rosso; L., Santi | |
Idarubicin in advanced breast cancer: a phase II study. | 1-gen-1986 | R., Lionetto; P., Pronzato; Conte, Pierfranco; M. R., Sertoli; D., Amoroso; R., Rosso |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile